A detailed history of Advisor Group Holdings, Inc. transactions in Tiziana Life Sciences LTD stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 10,000 shares of TLSA stock, worth $9,300. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,000
Holding current value
$9,300
% of portfolio
0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$0.81 - $1.45 $8,100 - $14,500
10,000 New
10,000 $9,000
Q3 2023

Nov 13, 2023

BUY
$0.6 - $0.82 $3,312 - $4,526
5,520 Added 144.16%
9,349 $6,000
Q2 2023

Aug 10, 2023

SELL
$0.65 - $1.29 $3 - $6
-5 Reduced 0.13%
3,829 $2,000
Q1 2023

May 12, 2023

BUY
$0.51 - $1.1 $1,952 - $4,211
3,829 Added 76580.0%
3,834 $4,000
Q4 2022

Feb 10, 2023

SELL
$0.56 - $0.78 $1,720 - $2,396
-3,072 Reduced 99.84%
5 $0
Q3 2022

Nov 14, 2022

BUY
$0.55 - $0.83 $1,689 - $2,549
3,072 Added 61440.0%
3,077 $2,000
Q2 2022

Aug 10, 2022

BUY
$0.66 - $1.06 $3 - $5
5 New
5 $0

Others Institutions Holding TLSA

About Tiziana Life Sciences Ltd


  • Ticker TLSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,273,000
  • Market Cap $95.1M
  • Description
  • Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...
More about TLSA
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.